Asplenia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Asplenia}} | {{Asplenia}} | ||
{{CMG}} {{AE}}{{ | {{CMG}} {{AE}} {{Kalpana Giri}} | ||
Revision as of 11:51, 20 July 2021
|
Asplenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asplenia risk factors On the Web |
|
American Roentgen Ray Society Images of Asplenia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalpana Giri, MBBS[2]
Overview
Common risk factors include: Trauma; atraumatic indication for splenectomy includes: hematological autoimmune disorder, Idiopathic Thrombocytopenic Purpura (ITP), Autoimmune Hemolytic Anemia (AIHA); Surgery includes: unexplained splenomegaly, autoimmune, malignant. Less Common Risk Factors include: mutation in gene RPSA and human genes, connexin 43 and ZIC3.
Risk Factors
Common Risk Factors
- Common risk factors in the development of asplenia include:
Less Common Risk Factors
- Less common risk factor include:
- mutations in the gene RPSA, is a risk factor for Isolated asplenia.[3]
- Two human genes, connexin 43 and ZIC3, is a risk factor for heterotaxy syndrome.[4]
References
- ↑ Erdem SB, Genel F, Erdur B, Ozbek E, Gulez N, Mese T (2015). "Asplenia in children with congenital heart disease as a cause of poor outcome". Cent Eur J Immunol. 40 (2): 266–9. doi:10.5114/ceji.2015.52841. PMC 4637402. PMID 26557043.
- ↑ Browning MG, Bullen N, Nokes T, Tucker K, Coleman M (2017). "The evolving indications for splenectomy". Br J Haematol. 177 (2): 321–324. doi:10.1111/bjh.14060. PMID 27018168.
- ↑ Bolze A (2014). "[Connecting isolated congenital asplenia to the ribosome]". Biol Aujourdhui. 208 (4): 289–98. doi:10.1051/jbio/2015001. PMID 25840456.
- ↑ Ahmed SA, Zengeya S, Kini U, Pollard AJ (2010). "Familial isolated congenital asplenia: case report and literature review". Eur J Pediatr. 169 (3): 315–8. doi:10.1007/s00431-009-1030-0. PMID 19618213.